Case number 1:22-cv-00141
Sanofi-Aventis U.S. LLC et al v. Aurobindo Pharma Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 29, 2022 | 7 | Stipulation of Dismissal (2) Docket Text: STIPULATION and Order of Dismissal, by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Fahnestock, Derek) Modified on 4/29/2022 (nms). |
| Apr 29, 2022 | 8 | Order (2) Docket Text: SO ORDERED Granting [7] Stipulation and Order of Dismissal with prejudice (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 4/29/2022. (nms) |
| Apr 29, 2022 | 9 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,583,110 B2; 10,716,777 B2; 8,927,592 B2. (Attachments: # (1) Order)(nms) |
| Apr 29, 2022 | 9 | Order (2) |
| Feb 2, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Feb 1, 2022 | 6 | Main Document (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to AuroMedics Pharma LLC on 2/1/2022; Aurobindo Pharma Limited on 2/1/2022; Eugia Pharma Specialties Limited on 2/1/2022. (Attachments: # (1) Summons Issued, # (2) Summons Issued)(smg) |
| Feb 1, 2022 | 6 | Summons Issued (2) |
| Feb 1, 2022 | 6 | Summons Issued (2) |
| Jan 31, 2022 | 1 | Main Document (30) Docket Text: COMPLAINT for Patent Infringement filed against AuroMedics Pharma LLC, Aurobindo Pharma Limited, Eugia Pharma Specialties Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3792530.) - filed by Sanofi-Aventis U.S. LLC, and Sanofi Mature IP. (Attachments: # (1) Exhibit A-D, # (2) Civil Cover Sheet)(smg) |
| Jan 31, 2022 | 1 | Exhibit A-D (117) |
| Jan 31, 2022 | 1 | Civil Cover Sheet (2) |
| Jan 31, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (smg) |
| Jan 31, 2022 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/30/2021. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 6/30/2024. (smg) |
| Jan 31, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,583,110 B2 ; 10,716,777 B2 ; 8,927,592 B2. (smg) |
| Jan 31, 2022 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Sanofi Mature IP, Sanofi-Aventis U.S. LLC filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (smg) |
| Jan 31, 2022 | 1 | Complaint* (1) |
